<DOC>
	<DOCNO>NCT01150123</DOCNO>
	<brief_summary>This study evaluate safety immunogenicity Group B Streptococcus vaccine .</brief_summary>
	<brief_title>Safety Immunogenicity Group B Streptococcus Vaccine Healthy Women</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy female 1840 year age inclusive . Individuals pregnant nursing . Individuals previous immunization vaccine contain streptococcus antigen vaccine within 30 day enrollment 30 day study completion . Individuals history severe allergic reaction previous vaccination Individuals designate blood test within normal range</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Group B streptococcus</keyword>
	<keyword>GBS</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Group B streptococcus ( GBS ) disease</keyword>
</DOC>